Study

D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia. – Cost Effective Supplements

D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia.

Quick navigation


http://www.ncbi.nlm.nih.gov/pubmed/15780844


Conclusion of this study

These findings 1) indicate that risperidone and olanzapine efficacy might be augmented with D-serine adjuvant treatment; 2) confirm D-serine efficacy against main schizophrenia symptom domains; and 3) warrant the assessment of D-serine antipsychotic monotherapy for this illness.


Supplements analyzed in this study

D-Serine

Health conditions analyzed in this study

Schizophrenia


Slightly Positive
D-Serine


Functions related to this study

Mental health


Slightly Positive
D-Serine


Body systems related to this study


Nervous System
Scroll to top